
Tata Nifty MidSmall Healthcare Index Fund Direct Growth
Tata Nifty MidSmall Healthcare Index Fund Direct Growth
as on 30 Oct 2026
Tata Nifty MidSmall Healthcare Index Fund Direct Growth is a mutual fund scheme launched on 26 Apr 2024. The current NAV stands at ₹15.2425 as of 30 Oct 2026. From the funds total AUM, its top holdings include Lupin at 9.15%, Laurus Labs at 8.82%, Fortis Healthcare at 8.05%, Aurobindo Pharma at 6.64%, Glenmark Pharmaceuticals at 5.70%
Scheme Overview
- Inception Date : 26 Apr 2024
- AUM : ₹220.69 Cr
- 1Y Returns (CAGR) : 16.74%
- Expense Ratio : 0.56%
- Min. SIP : ₹100
- Min. Lumpsum : ₹5,000
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
1Y
₹ 6.10 L
3.50%
₹ 6.27 L
8.00%
₹ 6.57 L
16.74%
Total Investment
₹ 6,00,000
Returns
₹ 57,287 (16.74%)
Maturity Value
₹ 6,57,287
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 220.69 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹220.69 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 100.08% | ||
| Other | -0.08% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() L Lupin | 9.15% | |
![]() L Laurus Labs | 8.82% | |
![]() F Fortis Healthcare | 8.05% | |
![]() A Aurobindo Pharma | 6.64% | |
![]() G Glenmark Pharmaceuticals | 5.70% | |
![]() A Alkem Laboratories | 5.35% | |
![]() B Biocon | 5.09% | |
![]() M Mankind Pharma | 4.47% | |
![]() I IPCA Laboratories | 3.52% | |
![]() K Krishna Institute of Medical Sciences | 3.12% | |
![]() A Aster DM Healthcare | 3.07% | |
![]() G Gland Pharma | 2.98% | |
![]() J J B Chemicals and Pharmaceuticals | 2.95% | |
![]() W Wockhardt | 2.79% | |
![]() S Sai Life Sciences | 2.66% | |
![]() N Neuland Laboratories | 2.45% | |
![]() A Abbott | 2.33% | |
![]() N Narayana Hrudayalaya | 2.18% | |
![]() D Dr. Lal Path Labs | 2.08% | |
![]() A Ajanta Pharma | 2.05% | |
![]() G Granules | 1.87% | |
![]() P Piramal Pharma | 1.78% | |
![]() O Onesource Specialty Pharma | 1.68% | |
![]() G Global Health | 1.68% | |
![]() G GlaxoSmithKline Pharmaceuticals | 1.52% | |
![]() N Natco Pharma | 1.52% | |
![]() S Syngene International | 1.40% | |
![]() C Cohance Lifesciences | 1.17% | |
![]() P Pfizer | 1.16% | |
![]() P Poly Medicure | 0.86% | |
![]() N Net Current Liabilities | 0.17% | |
![]() A A) Repo | 0.09% |
Fund Comparison
Fund Details
52W High NAV
-
Min. SIP Amount
₹ 100.00
Min. Lumpsum Amount
₹ 5,000.00
AUM (in Cr.)
₹ 220.69
Expense Ratio
0.56%
Lock-in Period
No Lock in Period
52W Low NAV
-
Inception Date
26 Apr 2024
Fund Age
2 Yrs
Benchmark
Nifty MidSmall Healthcare Index (TRI)
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit load of 0.25%, if redeemed within 15 days.
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Rakesh Indrajeet Prajapati | B.Com |
| Nitin Bharat Sharma | MFM (Master's degree in financial management), BAF (Bachelor of Commerce-Accounting & Finance) |
Fund Objective
The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
Tata Mutual Fund
No. of Schemes
61
Total AUM
₹ 2,13,620.14 Cr
Contact Details
1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051
Contact Details
1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051
FAQs
When was Tata Nifty MidSmall Healthcare Index Fund launched?
What is the current NAV of Tata Nifty MidSmall Healthcare Index Fund?
What is the AUM of Tata Nifty MidSmall Healthcare Index Fund?
What is the rate of return of Tata Nifty MidSmall Healthcare Index Fund?
- In the past 1Y: 16.74%
- In the past 3Y: 0.00%
- In the past 5Y: 0.00%
What is the expense ratio of Tata Nifty MidSmall Healthcare Index Fund?
What is exit load of Tata Nifty MidSmall Healthcare Index Fund?
What is the portfolio of Tata Nifty MidSmall Healthcare Index Fund?
- Lupin: 9.15%
- Laurus Labs: 8.82%
- Fortis Healthcare: 8.05%
- Aurobindo Pharma: 6.64%
- Glenmark Pharmaceuticals: 5.70%
Top 3 sectoral holdings include:
- Healthcare: 100.08%
- Others: 0.27%
How risky is investing in Tata Nifty MidSmall Healthcare Index Fund?
Who is the fund manager Tata Nifty MidSmall Healthcare Index Fund?
What is the minimum investment required in Tata Nifty MidSmall Healthcare Index Fund?
How to invest in Tata Nifty MidSmall Healthcare Index Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App

































